CCS & SCIRENT is a strategic partnership that delivers on US/OUS programs. We offer an excellent network of high-performing trial sites in Europe and North America, regulatory consulting, as well as strong medical expertise in support of the design and execution of your programs

Meet us at

CCS & SCIRENT Patient recruitment experience & access

Heart Failure
(Including HFrEF, HFpEF and ADHF)

Chronic Myocarditis

Dilative and Hypertrophic Cardiomyopathy

Valvular Disease

Lipid disorders & Hypertension

Pulmonary Arterial Hypertension

Acute Ischemic Stroke

Atherosclerosis & CAD

Specialisation

> 1 %

Cardiovascular studies in a wide range of Patient profiles

Countries

1 +

Across Europe

Experience

1 yrs

Average experience in CV research of our team members

Focus

1 %

of the trials we conduct are in early phase development

Management

Leadership

Hans-Dirk Duengen PhD, MD, MBA

SCIRENT CEO and Scientific Director

Hans-Dirk Duengen is the founder and CEO of SCIRENT. He has collected a wealth of national and international experience in initiating and executing clinical trials as a senior cardiologist at the Charité University Hospital Berlin. Also, he is the author of numerous scientific publications.

Elvis Tahirovic, MBA, MPH

SCIRENT CEO and Managing Director

Elvis Tahirovic is a Co-founder and Managing Director at SCIRENT. He has more than 15 years of experience as a global project manager in the healthcare sector. He is responsible for the company’s business strategy and finances.

Jovan Veskovic, MPH, Dipl. Ecc

SCIRENT CFO and Director Eastern Europe

Jovan Veskovic is a Co-Founder and the Regional Director Eastern Europe at SCIRENT. Since the beginning, he brings in his know-how and passion for managing global clinical trials. He is a management executive with degrees in Public Health and Economics.

Maximilian Posch, MD, MPH

SCIRENT Chief Medical Officer

Maximilian Posch has a strong background in academic and industry-driven research. As a clinician of internal medicine and clinical pharmacology, he has profound expertise in early phase clinical trials and cardiovascular research. In his career, he conducted more than 200 trials and co-authored numerous peer-reviewed publications.

Book a meeting with our team

* required

If you have any problems with the form above, please get in touch with us directly: contact@scirent.com